Loncastuximab in high-risk and heavily pretreated relapsed / refractory diffuse large B-cell lymphoma: a real-world analysis from 21 US centers

Autor: Viktoriya Zelikson, Ashwath Gurumurthi, Yazeed Sawalha, Kaitlin Annunzio, Aditi Saha, Ning Dong, David Qualls, Behzad Amoozgar, Brad Kahl, John Baird, Pavan Challa, Scott F Huntington, Jennifer Santos, Steven Bair, Mayur Narkhede, Shuning Li, Zachary Frosch, Carrie Ho, Stephen D Smith, Allison Winter, Daniel Landsburg, Fateeha Furqan, Mehdi Hamadani, Katelin Baird, Jason Romancik, Hanan Alharthy, Jennie Law, Leyla Bojanini, Ranjana Advani, Boyu Hu, Patrick Connor Johnson, Natalie S. Grover, Mwanasha Merril, Jennifer L. Crombie, Nazila Shafagati, Cole Sterling, Loretta J. Nastoupil, Narendranath Epperla, Emily C Ayers

Publikováno v: Haematologica, Vol 999, Iss 1 (2024)

Outcomes in patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) are poor. Loncastuximab-teserine (Lonca) is an antibody drug conjugate (ADC) which was FDA approved for R/R DLBCL patients who have received at least 2 prior li

Externí odkaz: https://doaj.org/article/28e5c35c2c204cf6bb7601f5c351589e

Real-world evaluation of health-related quality of life in patients with diffuse large B-cell lymphoma based on a multinational survey

Autor: P. Connor Johnson, Abigail Bailey, Qiufei Ma, Neil Milloy, Jake Butcher, Isaac Sanderson, Sarah Weatherby, Rachael Meadows, Ruben G. W. Quek

Publikováno v: Frontiers in Oncology, Vol 14 (2024)

BackgroundReal-world health-related quality of life (HRQoL) data in patients with diffuse large B-cell lymphoma (DLBCL) are scarce. This study is to compare patient-reported outcomes in patients with DLBCL across therapy lines and countries.MethodsDa

Externí odkaz: https://doaj.org/article/beded96e92ab43d3a884dc7a818ad785

Salvage radiotherapy in relapsed/refractory large B-cell lymphoma after failure of CAR T-cell therapy

Autor: Hazim S. Ababneh, Andrea K. Ng, Matthew J. Frigault, Jeremy S Abramson, Patrick Connor Johnson, Caron A. Jacobson, Chirayu G. Patel

Publikováno v: Haematologica, Vol 108, Iss 11 (2023)

Despite the success of CD19-targeted chimeric antigen receptor (CAR T)-cell therapy in patients with relapsed/refractory large B-cell lymphoma (LBCL), there is a need for effective salvage strategies post-CAR T-cell therapy failure. We conducted a mu

Externí odkaz: https://doaj.org/article/4a2ced42a6da469fb8f751f77f667624

Book of Abstracts: 2019 Health Equity Summer Research Summit Organized by the Center of Excellence in Health Equity, Training and Research, Baylor College of Medicine, Houston, Texas 77030, USA on June 18th, 2019

Autor: A Uribe-Gomez, Abraham A. Salinas-Miranda, MD, PhD, Acara E. Turner, BS, Adriana M. Strutt, PhD, ABPP, Adrienne Joseph, BS, Alex Wright, BS, Alexander C. Martin, BS, Alexis N. Milton, BS, Amelia Khoei, BS, Amritha Kanakamedala, BA, Angie Iyinbor, BA, Anna O’Neal, BS, Asha Morrow, MD, Ashley M. Butler, PhD, Ashley Young, BS, Asim Shah, MD, Asna Matin, MD, Audrey E. Christiansen, PhD, Boubakari Ibrahimou, PhD, Breanna Alonzo, Chase Ossenkop, BS, Carli O’Neal, BS, Chih-Wei Hsu, PhD, Charles Ikeanyionwu, BS, Chinwe Anyanwu, MPH, Charlotte Rivas, BS, Chioma A. Ikedionwu, BS, Chioma Anugwom, BS, Christopher R. Broda, MD, Claire Bocchini, MD, Claire Cummins, MD, Cliona M. Rooney, PhD, Colton L. Keo-Meier, PhD, Connor Johnson, BS, Courtney Miller-Chism, MD, Courtney Titus, MEd, Crystal L. Parker, MPH, Cylaina Bird, BA, Daniel Mauck, MPH, David Persse, MD, FACEP, Deborah A. Austin, PhD, Deepa Dongarwar, MS, Deepa V. Cherla, MD, Dwayne Wolf, MD, Ph.D, Eleanor Bimla Schwartz, MD, MS, Elena Petrova, PhD, Elias Perli, BS, Elisabeth Shell, PhD, PA-C, Elizabeth U. Tran, MD, Elsa Baena, PhD, Elyse Lopez, BS, Estrellita “Lo” Berry, MPA, Evadne Rodriguez, BA, Fabrizia Faustinella, MD, PhD, FACP, Faith D. Ihekweazu, MD, MS, Faiz Jiwani, MD, MS, Gabriella P. Chmaitelli, BS, Galant Chan, MD, Haijun Wang, PhD, MPH, Hamisu M. Salihu, MD, PhD, Hannah L. Combs, PhD, Hayley Rogers, BS, Heather Haq, MD, MHS, Iberia Romina Sosa, MD, PhD, Irene E. Jose, BS, Isabel Griffin, MPH, J. Cao, Jane Montealegre, PhD, Jason L. Salemi, PhD, MPH, Jennifer Chang, PhD, Jennifer M. Stinson, PhD, JL Mills, Joann Schulte, DO, MPH, Joel Thomas, John Prochaska, PhD, John Saunders, MD, MS, Jonathan Go, BBA, Jonathan Lim, MD, Jordan Salley, BS, Josue Estiven Pineda, BS, Jules Tabilona, MD, Julie L. Holihan, MD, MS, Kanika Bowen-Jallow, MD, MMS, Karla Bernardi, MD, Karla Fredricks, MD, MPH, Katherine B. Salciccioli, MD, Keila N. Lopez, MD,MPH, Kenneth Barning, MD, Kevin Dat Vuong, MA, Korede K. Yusuf, MBBS, PhD, Kristopher Myers, MPH, Kyle Wilson, Larry E. Laufman, EdD, Latanya J. Love, MD, Lauren Nolan, BA, Lauren Schoen, Lillian Huang, MD, Lindsey M. King, PhD, MPH, Lisa F. Nunez, BS, Louis Brown, PhD, Luna Hernandez, Lynn Hydod, M. Agustina Rossetti, PhD, Madeleine Allman, MPH, Mahmood Khan, MD, Makenna Marty, MAS, MaKenzie D. Lee, BS, Maria A. Jaramillo, BS, Maria Vigil, BS, Mariaelena Boyle, Marina Masciale, MD, Marisa Hilliard, PhD, Marisela Munoz, Mary E. Dickinson, PhD, Meishon Bell, MS, Michele K. York, PhD, Michelle Loor, MD, Michelle Lopez, MD, MPH, Mike K. Liang, MD, Moez Karim Aziz, MSECE, Moriel Karla, BS, Nancy Osazuma, Natalya Ramirez, BS, Natasha Navejar, BS, Nicolás Cortés-Penfield, MD, Nicole B. Lyons, BS, Norma Perez, MD, DrPH, NR Barshes, Olivia A. Barron, BA, Oscar A. Olavarria, MD, Petra Constable, BA, Phyllis Nwokolo, BS, Precious Omokaro, BS, Premal Patel, MD, Prithvi Vallabh, BS, Puja Shah, BA, Rafeek A. Yusuf, MD, MS, MPH, Rebecca A. Rosero, BA, Rebecca Lunstroth, JD, MA, Renice Obure, MPH, Robert Beach, MD, Robin Goin-Kochel, PhD, Robin Parihar, MD, PhD, Roger Zoorob, MD, MPH, Ronee E. Wilson, PhD, Rosa Michelle Schmidt, MD, MPH, Rowland Pettit, BS, Sade C. Udoetuk, MD, Sadia Tasnim, Sara Khan, BA, Sareema Adnan, BS, Sean Rodriguez, BA, Sharmila Anandasabapathy, MD, Shawna Nesbitt, MD, Sheena Bhushan, MD, Sherene Sharath, SO Rogers, Son Dinh, BSA, Sophia Banu, MD, Stacey Rose, MD, FACP, Stacy Drake, Ph.D, MPH, RN, AFN-BC, D-AB, Stephanie Morain, PhD, MPH, Stephen R. McCauley, PhD, Sue Abdelaziz, BS, Tahir Malik, BS, Tara L. Rasmussen, PhD, Thomas Shum, Tiana Raphel, BA, Tien C. Ko, MD, Toi Harris, MD, Trevor Hadley, BS, Uchechukwu Akoma, BS, Uwem Bridgette Eduok, BSA, Victoria Armendariz, MS, Yasmin C. Cole-Lewis, PhD, MPH, Zaina Al-Mohtaseb, MD, Zenab Yusuf, MD, MPH

Publikováno v: International Journal of Maternal and Child Health and AIDS, Vol 9, Iss 2s (2020)

Copyright © 2020 Harris. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cit

Externí odkaz: https://doaj.org/article/67bfadcd915c47518aabd4323cdec3f7

Assessing the role of radiotherapy in patients with refractory or relapsed high-grade B-cell lymphomas treated with CAR T-cell therapy

Autor: Hazim S, Ababneh, Jeremy S, Abramson, P Connor, Johnson, Chirayu G, Patel

Publikováno v: Radiotherapy and Oncology. 175:65-72

An estimated 30-40% of patients with diffuse large B cell lymphoma (DLBCL) will either relapse or have refractory disease with first-line chemoimmunotherapy. The standard approach for relapsed/refractory disease is salvage chemotherapy followed by au

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77a04925997d5858daf911bb42968d8b
https://doi.org/10.1016/j.radonc.2022.08.007